诊断标准和治疗非结核性分枝杆菌肺病的决定

IF 2.8 3区医学 Q2 RESPIRATORY SYSTEM

Clinics in Chest Medicine Pub Date : 2023-09-01 DOI:10.1016/j.ccm.2023.07.003

David E. Griffith MD , Timothy R. Aksamit MD

引用次数: 0

摘要

非结核分枝杆菌（NTM）肺部疾病的诊断基于三个标准：患者症状、放射学表现和微生物学结果。微生物学标准是最复杂的，因为它需要不止一种阳性痰抗酸杆菌培养。临床医生面临着将诊断标准应用于可变患者症状、NTM致病性和宿主易感性的挑战。治疗NTM肺病的决定需要评估治疗的风险和益处以及患者接受治疗的意愿和能力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Diagnostic Criteria and the Decision to Treat Nontuberculous Mycobacterial Pulmonary Disease

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Clinics in Chest Medicine 医学-呼吸系统

CiteScore

9.10

自引率

1.80%

发文量

审稿时长

6-12 weeks

期刊介绍： Clinics in Chest Medicine updates those in the fields of anesthesia, critical care, and respiratory medicine on the latest trends in patient management, providing a sound basis for choosing the best treatment options. Published quarterly—in March, June, September, and December—each issue offers state-of-the-art reviews on a single topic, including diseases of air movement and airways, infectious lung disease, pulmonary vascular disease, sleep-related disorders, respiratory failure, and systemic disease.